Dermatology - European Medical Journal

Continue

Dermatology

Filter
10 Mins
30 Oct 2018

Is Complete Skin Clearance in Psoriasis the Answer?

Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…
9 Mins
30 Oct 2018

IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future

This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…
9 Mins
30 Oct 2018

From Evolution to Revolution: IL-23 in the Treatment of Psoriasis Patients

This symposium, which took place during the 2018 meeting of the European Academy of Dermatology and Venereology (EADV) in Paris, France, provided…
10 Mins
30 Oct 2018

Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis

Guselkumab is a monoclonal antibody targeting IL-23 that is approved for the treatment of patients with moderate-to-severe plaque psoriasis. Two of…
9 Mins
30 Oct 2018

Efficacy, Sustainability, and Patient-Reported Outcomes of Guselkumab to Treat Plaque Psoriasis in the Post-Approval Setting

Plaque psoriasis is an autoimmune condition characterised by the development of red, dry, scaly skin lesions that cause irritation and pain for patients…
10 Mins
30 Oct 2018

Editor’s Pick: Beneath the Skin: The Relationship Between Psychological Distress and the Immune System in Patients with Psoriasis

Psoriasis is a chronic autoimmune skin disease with significant physical and psychiatric comorbidities and affects 2–3% of people worldwide.
5 Mins
30 Oct 2018

A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis

The objective of this study was to conduct a systematic review of the available evidence on the treatment of herpes simplex labialis with U.S. Food and Drug Administration (FDA)-approved topical antibiotics.
8 Mins
30 Oct 2018

Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers

Chronic urticaria (CU) is characterised by intense recurrent itch, wheals, and/or angioedema, persisting for >6 weeks. CU can be subdivided into chronic…